Showing results (151-160 of 468) with videos related to

Sort By:
Pageof 47
The Prostate|January 1, 2008
Finasteride, prostate cancer, and weight gain: evidence for genetic or environmental factors that affect cancer outcomes during finasteride treatmentYoonJu Song, Catherine Tangen, Phyllis Goodman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approachMary W Redman, Catherine M Tangen, Phyllis J Goodman, et al.
Hematology/Oncology Clinics of North America|July 25, 2006
Chemoprevention of prostate cancerTimothy C Brand, Edith D Canby-Hagino, A Pratap Kumar, et al.
The Journal of Urology|May 16, 2006
The prostate cancer prevention trial: design, biases and interpretation of study resultsPhyllis J Goodman, Ian M Thompson, Catherine M Tangen, et al.
Clinical Prostate Cancer|March 30, 2004
Ten-year survival in patients with metastatic prostate cancerCatherine M Tangen, James R Faulkner, E David Crawford, et al.
Urologia Internationalis|May 26, 2012
The use of the finasteride-adjusted Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator in a Mexican referral population: a validation studyYuanyuan Liang, Norma S Ketchum, Christopher Louden, et al.
Cancer|May 31, 2013
The Prostate Cancer Prevention Trial risk calculator and the relationship between prostate-specific antigen and biopsy outcomeAndrew J Vickers, Daniel D Sjoberg, Donna P Ankerst, et al.
Investigative and Clinical Urology|March 7, 2019
Microbiome diversity in carriers of fluoroquinolone resistant Escherichia coliMichael A Liss, Robin J Leach, Elizabeth Rourke, et al.
JAMA|January 18, 2006
Erectile dysfunction and subsequent cardiovascular diseaseIan M Thompson, Catherine M Tangen, Phyllis J Goodman, et al.
World Journal of Urology|November 23, 2017
Men with family history of prostate cancer have a higher risk of disease recurrence after radical prostatectomyMark Thalgott, Martina Kron, Johannes M Brath, et al.
Pageof 47